Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1-Reference-Cited by-同舟云学术

Parallel Induction of CH505 B Cell Ontogeny-Guided Neutralizing Antibodies and tHIVconsvX Conserved Mosaic-Specific T Cells against HIV-1

Published:2019-09 Issue: Volume:14 Page:148-160
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Wee Edmund G.,Moyo Nathifa A.,Saunders Kevin O.,LaBranche Celia,Donati Filippo,Capucci Silvia,Parks Robert,Borthwick Nicola,Hannoun Zara,Montefiori David C.,Haynes Barton F.,Hanke Tomáš

Funder

Medical Research Council

UK Department for International Development

NIH

European AIDS Vaccine Initiative

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference71 articles.

1. HIV-Host Interactions: Implications for Vaccine Design;Haynes;Cell Host Microbe,2016

2. Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables;Doria-Rose;J. Virol.,2010

3. The neutralization breadth of HIV-1 develops incrementally over four years and is associated with CD4+ T cell decline and high viral load during acute infection;Gray;J. Virol.,2011

4. Factors associated with the development of cross-reactive neutralizing antibodies during human immunodeficiency virus type 1 infection;Sather;J. Virol.,2009

5. Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm;Simek;J. Virol.,2009

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of ChAdOx1 or DNA Prime Vaccination on Magnitude, Breadth, and Focus of MVA-Boosted Immunogen-Specific T Cell Responses;Vaccines;2024-03-07

2. Safety and Broad Immunogenicity of HIVconsvX Conserved Mosaic Candidate T-Cell Vaccines Vectored by ChAdOx1 and MVA in HIV-CORE 006: A Double-Blind, Randomized, Placebo-Controlled Phase 1 Trial in Healthy Adults Living Without HIV-1 in Eastern and Southern Africa;2024

3. Generating and measuring effective vaccine-elicited HIV-specific CD8+ T cell responses;Current Opinion in HIV and AIDS;2023-09-20

4. Human Immunodeficiency Virus Vaccines;Plotkin's Vaccines;2023

5. Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies;Nature Reviews Immunology;2022-08-12